The American Journal of Managed Care

Abstracts at ASCO Quality Show Uptake of Rapid NGS, Biomarker Testing Across OneOncology

Two abstracts involving real-world data (RWD) presented at the 2021 American Society of Clinical Oncology Quality Care Symposium tracked the uptake of next-generation sequencing (NGS) and biomarker ...
GEN

Reimbursing NGS Testing

New Working Group to Evaluate Clinical Utility of NGS-Based Testing to Inform Coverage After many years of steady development in DNA sequencing, the scientific community is reaching an exciting ...
Labroots

test NGS testing and the single day sequencing workflow

Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic ...
The American Journal of Managed Care

Analysis Supports Concurrent Plasma NGS, Tissue Testing for NSCLC

Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients. Carrying out plasma next-generation sequencing ...
Medscape

New Guidelines to Help Payers Navigate NGS Testing in Cancer

Next-generation sequencing (NGS) technologies enable the rapid generation of data by their ability to sequence massive amounts of DNA in parallel, using diverse methodologies. Some NGS tests are used ...
Business Insider

OneOncology Presents Abstracts at ASCO Highlighting Importance of Increasing NGS Testing

NASHVILLE, Tenn., May 25, 2023 /PRNewswire/ -- At the 2023 ASCO annual meeting, investigators from OneOncology's clinical team will present Oral Abstracts using real-world data to evidence better ...
MedPage Today

Incorporation of Plasma-based NGS to Improve Guideline-Concordant Molecular Testing in Patients With Newly Diagnosed Metastatic Nonsquamous NSCLC

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Between 01/2019, and 12/2019, 170 patients with newly diagnosed ...
PharmiWeb

MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions

Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time matters most. By shrinking the diagnostic delay, the time ...
JD Supra

New CMS National Coverage Determination and FDA Regulatory Approach: the Next Generation for NGS Testing Policy?

On March 16, 2018, the Centers for Medicare and Medicaid Services (CMS) finalized a national coverage determination (NCD) for next-generation sequencing (NGS) tests for cancer, marking a significant ...
Medscape

The New Reflex: Why IHC and RNA Testing Must Join NGS for Lung Cancer

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
ascopubs.org

Rates of first next-generation sequencing (NGS) testing at the end of life in patients (pts) with advanced urothelial carcinoma (aUC).

Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.
Nasdaq

Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)

Fulgent Genetics will partner with MedScan Laboratory to launch one of the market’s first COVID-19 tests based on comprehensive Next Generation Sequencing technology TEMPLE CITY, Calif., March 17, ...